Previous Article | Next Article 
Journal of Virology, May 2000, p. 4110-4115, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Induction of Indolamine 2,3-Dioxygenase in Primary
Human Macrophages by Human Immunodeficiency Virus Type 1 Is
Strain Dependent
Ross S.
Grant,1
Hassan
Naif,2,*
Sophie J.
Thuruthyil,1
Najla
Nasr,2
Tamantha
Littlejohn,3
Osamu
Takikawa,3 and
Vimal
Kapoor1,*
School of Physiology and Pharmacology,
Faculty of Medicine, University of New South Wales, Sydney
2052,1 Centre for Virus Research,
University of Sydney, Westmead Hospital, Westmead
2145,2 and Australian Cataract
Research Foundation, University of Wollongong, Wollongong
2522,3 New South Wales, Australia
Received 7 June 1999/Accepted 28 January 2000
Increased kynurenine pathway metabolism has been implicated in the
etiology of AIDS dementia complex (ADC). The rate-limiting enzyme for
this pathway is indolamine 2,3-dioxygenase (IDO). We tested the
efficacy of different strains of human immunodeficiency virus type 1 (HIV1-BaL, HIV1-JRFL, and HIV1-631) to induce IDO in cultured human
monocyte-derived macrophages (MDM). A significant increase in both IDO
protein and kynurenine synthesis was observed after 48 h in MDM
infected with the brain-derived HIV-1 isolates, laboratory-adapted (LA)
HIV1-JRFL, and primary isolate HIV1-631. In contrast, almost no
kynurenine production or IDO protein was evident in MDM infected
with the highly replicating macrophage-tropic LA strain HIV1-BaL. The
induction of IDO and kynurenine synthesis by HIV1-JRFL and HIV1-631
declined to baseline levels by day 8 postinfection. Abundant HIV-1
replication did not reduce the ability of exogenous gamma interferon
(IFN-
) to induce IDO and kynurenine synthesis in HIV-infected MDM.
The addition of anti-IFN-
antibody to MDM infected with HIV1-JRFL
resulted in an absence of detectable IDO protein after 48 h and a
decrease of 64% ± 1% in supernatant kynurenine concentration.
Together, these results indicate that only selected strains of HIV-1
are capable of inducing IDO synthesis and subsequent kynurenine
metabolism in MDM. The induction of IDO, while apparently independent
of replication capacity, appears to be mediated by a transient
production of IFN-
in MDM responding to the initial infection with
selected strains of HIV-1.
*
Corresponding author. Mailing address for V. Kapoor:
School of Physiology and Pharmacology, Faculty of Medicine, University of New South Wales, Sydney 2052, Australia. Phone: 61-2 93853741. Fax:
61-2 93851099. E-mail: V.Kapoor{at}unsw.edu.au. Mailing
address for H. Naif: Centre for Virus Research, University of Sydney, Westmead Hospital, Westmead 2145, Australia. Phone: 61-2 98456311. Fax:
61-2 98458300. E-mail:
hassann{at}westgate.wh.usyd.edu.au.
Journal of Virology, May 2000, p. 4110-4115, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Boasso, A., Vaccari, M., Fuchs, D., Hardy, A. W., Tsai, W.-P., Tryniszewska, E., Shearer, G. M., Franchini, G.
(2009). Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques. J. Immunol.
182: 4313-4320
[Abstract]
[Full Text]
-
Suh, H.-S., Zhao, M.-L., Rivieccio, M., Choi, S., Connolly, E., Zhao, Y., Takikawa, O., Brosnan, C. F., Lee, S. C.
(2007). Astrocyte Indoleamine 2,3-Dioxygenase Is Induced by the TLR3 Ligand Poly(I:C): Mechanism of Induction and Role in Antiviral Response. J. Virol.
81: 9838-9850
[Abstract]
[Full Text]
-
Braun, D., Longman, R. S., Albert, M. L.
(2005). A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood
106: 2375-2381
[Abstract]
[Full Text]
-
Potula, R., Poluektova, L., Knipe, B., Chrastil, J., Heilman, D., Dou, H., Takikawa, O., Munn, D. H., Gendelman, H. E., Persidsky, Y.
(2005). Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood
106: 2382-2390
[Abstract]
[Full Text]
-
Obojes, K., Andres, O., Kim, K. S., Daubener, W., Schneider-Schaulies, J.
(2005). Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon. J. Virol.
79: 7768-7776
[Abstract]
[Full Text]
-
Staniszewska, M. M., Nagaraj, R. H.
(2005). 3-Hydroxykynurenine-mediated Modification of Human Lens Proteins: STRUCTURE DETERMINATION OF A MAJOR MODIFICATION USING A MONOCLONAL ANTIBODY. J. Biol. Chem.
280: 22154-22164
[Abstract]
[Full Text]
-
Andersson, J., Boasso, A., Nilsson, J., Zhang, R., Shire, N. J., Lindback, S., Shearer, G. M., Chougnet, C. A.
(2005). Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients. J. Immunol.
174: 3143-3147
[Abstract]
[Full Text]
-
Boasso, A., Herbeuval, J.-P., Hardy, A. W., Winkler, C., Shearer, G. M.
(2005). Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood
105: 1574-1581
[Abstract]
[Full Text]
-
Valle, M., Price, R. W., Nilsson, A., Heyes, M., Verotta, D.
(2004). CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain
127: 1047-1060
[Abstract]
[Full Text]
-
Mellor, A. L., Munn, D. H.
(2003). Tryptophan Catabolism and Regulation of Adaptive Immunity. J. Immunol.
170: 5809-5813
[Full Text]
-
Burudi, E. M. E., Marcondes, M. C. G., Watry, D. D., Zandonatti, M., Taffe, M. A., Fox, H. S.
(2002). Regulation of Indoleamine 2,3-Dioxygenase Expression in Simian Immunodeficiency Virus-Infected Monkey Brains. J. Virol.
76: 12233-12241
[Abstract]
[Full Text]
-
Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G.
(2002). Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites. JEM
196: 447-457
[Abstract]
[Full Text]